Tian An Medicare Limited (COLRF)
OTCMKTS · Delayed Price · Currency is USD
0.0800
-0.0380 (-32.20%)
At close: May 19, 2025
Tian An Medicare Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,589 | 1,627 | 1,569 | 1,438 | 1,463 | 1,194 |
Other Revenue | - | - | - | 0.02 | 0.02 | 0.03 |
| 1,589 | 1,627 | 1,569 | 1,438 | 1,463 | 1,194 | |
Revenue Growth (YoY) | -2.49% | 3.72% | 9.11% | -1.75% | 22.56% | -2.72% |
Cost of Revenue | 1,290 | 1,305 | 1,287 | 1,184 | 1,203 | 973.42 |
Gross Profit | 298.97 | 322.65 | 282.23 | 253.7 | 260.23 | 220.73 |
Selling, General & Admin | 229.62 | 230.55 | 235.47 | 259.25 | 225.43 | 228.08 |
Other Operating Expenses | -14.04 | -13.14 | -23.56 | 19.31 | 46.49 | 14.61 |
Operating Expenses | 215.59 | 217.41 | 211.91 | 278.56 | 271.92 | 242.69 |
Operating Income | 83.38 | 105.23 | 70.33 | -24.86 | -11.69 | -21.96 |
Interest Expense | -25.12 | -29.11 | -47.81 | -59.02 | -58.25 | -49.92 |
Interest & Investment Income | 28.67 | 32.5 | 24.47 | 3.96 | 1.42 | 4.08 |
Currency Exchange Gain (Loss) | -3.4 | -15.24 | -0.62 | -15.65 | -6.01 | 16.38 |
EBT Excluding Unusual Items | 83.53 | 93.37 | 46.36 | -95.57 | -74.53 | -51.43 |
Impairment of Goodwill | - | - | - | - | -34.04 | - |
Gain (Loss) on Sale of Investments | -1.27 | -1.67 | -0.64 | -2.7 | -4.78 | -11.45 |
Gain (Loss) on Sale of Assets | -0.45 | - | - | -0.47 | 0.02 | 0.02 |
Asset Writedown | -47.27 | -34.69 | -4.92 | -23.95 | 2.29 | -34.72 |
Other Unusual Items | - | - | - | 5.52 | 0.58 | 1.02 |
Pretax Income | 34.53 | 57 | 40.81 | -117.17 | -110.47 | -96.56 |
Income Tax Expense | 6.9 | 15.03 | 14.91 | 1.98 | 16.8 | 8.58 |
Earnings From Continuing Operations | 27.63 | 41.98 | 25.89 | -119.15 | -127.27 | -105.14 |
Minority Interest in Earnings | -8.54 | -13.2 | -11.22 | -4.43 | -10.03 | -6.79 |
Net Income | 19.09 | 28.77 | 14.68 | -123.57 | -137.3 | -111.93 |
Net Income to Common | 19.09 | 28.77 | 14.68 | -123.57 | -137.3 | -111.93 |
Net Income Growth | -45.49% | 96.03% | - | - | - | - |
Shares Outstanding (Basic) | 1,085 | 1,086 | 924 | 724 | 724 | 724 |
Shares Outstanding (Diluted) | 1,085 | 1,086 | 924 | 724 | 724 | 724 |
Shares Change (YoY) | -0.22% | 17.55% | 27.60% | - | - | - |
EPS (Basic) | 0.02 | 0.03 | 0.02 | -0.17 | -0.19 | -0.15 |
EPS (Diluted) | 0.02 | 0.03 | 0.02 | -0.17 | -0.19 | -0.15 |
EPS Growth | -45.37% | 66.75% | - | - | - | - |
Free Cash Flow | -54.15 | -86.91 | 160.3 | -67.53 | 64.95 | -116.23 |
Free Cash Flow Per Share | -0.05 | -0.08 | 0.17 | -0.09 | 0.09 | -0.16 |
Dividend Per Share | 0.020 | 0.020 | 0.010 | - | - | - |
Dividend Growth | 100.00% | 100.00% | - | - | - | - |
Gross Margin | 18.82% | 19.83% | 17.99% | 17.64% | 17.78% | 18.48% |
Operating Margin | 5.25% | 6.47% | 4.48% | -1.73% | -0.80% | -1.84% |
Profit Margin | 1.20% | 1.77% | 0.94% | -8.59% | -9.38% | -9.37% |
Free Cash Flow Margin | -3.41% | -5.34% | 10.22% | -4.70% | 4.44% | -9.73% |
EBITDA | 172.44 | 196.63 | 154.02 | 69.43 | 86.73 | 86.49 |
EBITDA Margin | 10.85% | 12.08% | 9.82% | 4.83% | 5.93% | 7.24% |
D&A For EBITDA | 89.06 | 91.4 | 83.69 | 94.29 | 98.42 | 108.46 |
EBIT | 83.38 | 105.23 | 70.33 | -24.86 | -11.69 | -21.96 |
EBIT Margin | 5.25% | 6.47% | 4.48% | -1.73% | -0.80% | -1.84% |
Effective Tax Rate | 19.98% | 26.36% | 36.55% | - | - | - |
Revenue as Reported | 1,627 | 1,627 | 1,569 | 1,438 | 1,463 | 1,194 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.